Image of patient at Proton Center.

Children battling cancer receive expert, pediatric care at Arkansas Children’s

Arkansas Children’s not only provides care for 90% of Arkansas’ pediatric cancer patients — we also provide care for children from all over the region battling malignant and non-malignant disorders. Currently, the team is facilitating active treatment plans for approximately 290 patients.

Two Ways to Refer a Patient

Best Children's Hospitals - US News & World Report

Nationally Ranked Pediatric Care

Arkansas Children's provides right-sized care for your child. U.S. News & World Report has ranked Arkansas Children's in seven specialties, including Cancer.

Pediatric Blood and Marrow Transplant and Cellular Therapy (BMT-CT)

Arkansas Children’s is committed to providing access to leading-edge treatments, including bone marrow transplant and cellular therapies.

Arkansas Children’s Hospital offers both allogeneic and autologous blood marrow transplants to treat cancers, immune disorders and blood diseases.

Our program is also a certified CAR-T site. Chimeric antigen receptor (CAR) T cells uses the patient’s own genetically modified T cells to attack and kill cancer cells. This therapy is used to treat some of the most challenging pediatric cancers including B-cell acute lymphoblastic leukemia (ALL). We are currently using CAR-T cell treatment known as tisagenlecleucel (Kymriah). 

Foundation for the Accreditation of Cellular TherapyOur autologous program is accredited by the internationally recognized Foundation for the Accreditation of Cellular Therapy (FACT).

Conditions We Treat

  • Anemia
  • Bone marrow failure conditions
  • Bone tumors
  • Brain and spinal cord tumors
  • Germ cell tumors
  • Hemophilia and bleeding disorders
  • Histiocytosis
  • Leukemia
  • Liver tumors
  • Lymphoma - Hodgkin and Non-Hodgkin Lymphoma
  • Neuroblastoma
  • Other malignant diseases
  • Sickle cell disease
  • Soft-tissue sarcomas
  • Solid tumors
  • Thrombocytopenia

Innovative Research

The hematology/oncology experts at Arkansas Children’s are working toward participating in more cancer research studies and providing more complex and experimental cancer treatments for our patients.

  • The Hematology/Oncology program is wide-reaching across the Arkansas Children’s institution—including Arkansas Children’s Hospital, Arkansas Children’s Northwest and Arkansas Children’s Research Institute (ACRI).

  • As a Children’s Oncology Group member, Arkansas Children’s participates in National Cancer Institute-funded clinical research protocols.

  • Arkansas Children’s helped bring proton therapy to the region. The alternative to radiation treatment is particularly effective in treating solid cancer tumors and is widely used to treat children with cancer, as children are particularly sensitive to radiation therapy.

  • ACRI obtained equipment and bolstered capabilities and personnel to begin the pediatric precision medicine program.

 

Dedicated Cancer Survivorship Clinic

The THRIVE clinic at Arkansas Children’s Hospital is the state’s only survivorship clinic for children with cancer. It offers a multidisciplinary team to help children and families navigate life for up to 10 years after treatment ends.

In addition to medical challenges, the program addresses mental health concerns, learning difficulties, social reintegration challenges and fears of relapse. Integrated treatments ensure patients go beyond surviving cancer — they THRIVE.